Swine Flu Scare: Stock Market Bonanza for “Politically Connected” BioTech Companies

The Swine Flu scare has boosted the stock market values of Big Pharma. Following initial reports from Mexico on the influenza outbreak, the demand for anti-flu drugs has skyrocketed.

Supported by media disinformation, an atmosphere of fear and intimidation has unfolded. Health “emergencies” have been declared in various parts of the US.

The most sought after influenza drugs are Tamiflu and Relenza. Treatment courses by the US government have been released from the national stockpile “to make sure health care providers are ready for any escalation in cases.”

Tamiflu is produced by the Swiss pharmaceutical giant Hoffman-La Roche on behalf of a US based biotech company Gilead Sciences, Inc. While the drug is produced by Roche, it was developed by Gilead Sciences Inc. which owns the intellectual property rights.

Former Defense Secretary Donald Rumsfeld was one of the major shareholders of Gilead Sciences. In 1997, Rumsfeld was appointed Chairman of Gilead Sciences, Inc., a position which he held until becoming Secretary of Defence in the Bush administration in 2001. Rumsfeld was on the Board of Directors from the establishment of Gilead in 1987.

Fortune Magazine in a report published at the height of 2005 bird flu crisis, described Gilead as one of the most politically connected companies in the biotech industry. Rumsfeld’s interests and/or holdings in Gilead following his resignation in 2006 are not known.

Stock Values

The share price of Gilead on the NYSE has risen substantially since the announcement of the Mexican swine flu outbreak (see graph):

Chart for Gilead Sciences Inc. (GILD)

 “The U.S. government released a quarter of its stockpiles of the drugs after declaring a national health emergency with 40 laboratory-confirmed cases of swine flu. Seven of those cases are in California, 28 in New York City, two each in Texas and Kansas, and one in Ohio.

Mexico raised the suspected death toll from its outbreak to 149 people — 20 of those confirmed as swine flu — and cancelled all schools until May 6. Nearly 2,000 people there have been hospitalized with serious cases of pneumonia.

Antiviral drugs are prescription medicines active against influenza viruses, including swine influenza viruses, according to the Centers for Disease Control. Swine influenza A viruses detected in the United States and Mexico appear resistant to two antiviral drugs — amantadine and rimantadine — but laboratory tests indicate the viruses are sensitive to Tamiflu, also known as oseltamivir, and Relenza, which is known as zanamivir.

The Tamiflu oral antiviral, approved in the U.S. to treat and prevent influenza A and B virus infection in people age one or older, is sold by F. Hoffmann-La Roche Ltd., which pays sales-related royalties to Gilead. Roche said it has 3 million packages of Tamiflu on standby — part of 5 million treatments donated to the U.N. health agency in 2006 — and can deliver the drug anywhere within 24 hours.” (San Francisco Business Times, 27 April 2009)

 

AMERICA’S “WAR ON TERRORISM”

by Michel Chossudovsky

CLICK TO ORDER

America’s “War on Terrorism”

In this new and expanded edition of Michel Chossudovsky’s 2002 best seller, the author blows away the smokescreen put up by the mainstream media, that 9/11 was an attack on America by “Islamic terrorists”.  Through meticulous research, the author uncovers a military-intelligence ploy behind the September 11 attacks, and the cover-up and complicity of key members of the Bush Administration.

The expanded edition, which includes twelve new chapters focuses on the use of 9/11 as a pretext for the invasion and illegal occupation of Iraq, the militarisation of justice and law enforcement and the repeal of democracy.

According to Chossudovsky, the  “war on terrorism” is a complete fabrication based on the illusion that one man, Osama bin Laden, outwitted the $40 billion-a-year American intelligence apparatus. The “war on terrorism” is a war of conquest. Globalisation is the final march to the “New World Order”, dominated by Wall Street and the U.S. military-industrial complex.

September 11, 2001 provides a justification for waging a war without borders. Washington’s agenda consists in extending the frontiers of the American Empire to facilitate complete U.S. corporate control, while installing within America the institutions of the Homeland Security State.

Chossudovsky peels back layers of rhetoric to reveal a complex web of deceit aimed at luring the American people and the rest of the world into accepting a military solution which threatens the future of humanity.

The last chapter includes an analysis of the London  7/7 Bomb Attacks.

CLICK TO ORDER (mail order or online order)

America’s “War on Terrorism”


Comment on Global Research Articles on our Facebook page

Become a Member of Global Research


About the author:

Michel Chossudovsky is an award-winning author, Professor of Economics (emeritus) at the University of Ottawa, Founder and Director of the Centre for Research on Globalization (CRG), Montreal, Editor of Global Research.  He has taught as visiting professor in Western Europe, Southeast Asia, the Pacific and Latin America. He has served as economic adviser to governments of developing countries and has acted as a consultant for several international organizations. He is the author of eleven books including The Globalization of Poverty and The New World Order (2003), America’s “War on Terrorism” (2005), The Global Economic Crisis, The Great Depression of the Twenty-first Century (2009) (Editor), Towards a World War III Scenario: The Dangers of Nuclear War (2011), The Globalization of War, America's Long War against Humanity (2015). He is a contributor to the Encyclopaedia Britannica.  His writings have been published in more than twenty languages. In 2014, he was awarded the Gold Medal for Merit of the Republic of Serbia for his writings on NATO's war of aggression against Yugoslavia. He can be reached at [email protected]

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]